EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patterns of Antibiotic Use in Hospitalized COVID-19 Patients and Association with Secondary Infections and Outcomes

Diana-Maria Mateescu iD, Ana-Olivia Toma, Dragos-Mihai Gavrilescu, Adrian-Cosmin Ilie, Eduard Florescu, Ovidiu Rosca iD, Cristian Oancea, Stela Iurciuc, Camelia-Oana Muresan iD, Alexandra Enache

Antibiotics · 25.02.2026 · 15 (3) · 240

DOI: 10.3390/antibiotics15030240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 25.02.2026. Verfasst von Diana-Maria Mateescu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, Department of General Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romani…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babeș University of Medicine and Pharmacy Timișoara, Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Antibiotic exposure is highly prevalent in patients hospitalized with COVID-19, yet the relationship between specific prescribing patterns, microbiologically confirmed secondary infections, and clinical outcomes remains incompletely understood, particularly in settings with high antimicrobial resistance.

Methods

This single-center retrospective observational cohort included 395 consecutive adults hospitalized with RT-PCR-confirmed COVID-19 in a tertiary infectious diseases hospital. Data on demographics, comorbidities, baseline disease severity, antimicrobial prescribing (timing, WHO AWaRe class, duration, monotherapy/combination, escalation/de-escalation), microbiological results, and outcomes were extracted from electronic records and the microbiology information system. The primary outcome was microbiologically confirmed secondary infection; secondary outcomes were ICU admission, invasive mechanical ventilation, length of stay, and in-hospital mortality. Multivariable logistic regression and survival analyses assessed associations between antibiotic exposure and outcomes.

Results

Overall, 88.4% of patients received systemic antibiotics, predominantly initiated within 24 h of admission and mostly empirical; 58.7% received combination regimens, with frequent use of Watch/Reserve agents. Secondary infections occurred in 28.4% of patients, were hospital-acquired in 82.1%, and involved multidrug-resistant organisms in 41.1% of cases. Any antibiotic exposure was independently associated with secondary infection (adjusted odds ratio, aOR 2.15; 95% CI 1.42–3.27), while prolonged therapy (≥7 days), Watch/Reserve use, and early initiation showed additional risk gradients. Antibiotic exposure was also associated with higher odds of ICU admission, invasive mechanical ventilation, prolonged hospitalization, and in-hospital mortality after adjustment.

Conclusions

In this real-world COVID-19 cohort, broad and largely empirical antibiotic use was common and strongly associated with hospital-acquired, often multidrug-resistant secondary infections and worse clinical outcomes. These findings highlight the need for reinforced antimicrobial stewardship focusing on restrictive early broad-spectrum use, AWaRe-guided agent selection, systematic 48–72 h reassessment with de-escalation, and minimization of treatment duration.

Schlagwörter

Stichwörter der Autor:innen

AWaRe classificationCOVID-19 hospitalizationantibiotic exposureantimicrobial resistanceantimicrobial stewardshipclinical outcomeshospital-acquired infectionintensive caremultidrug-resistant pathogenssecondary infections

Autor:innen und Institutionen

  • Doctoral School, Department of General Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Discipline of Dermatology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Center for the Morphologic Study of the Skin (MORPHODERM), "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timișoara, Romania.
  • Department of Orthodontics, Dental District, Zăgazului 3, One Floreasca Vista, 014261 Bucharest, Romania.
  • Department of Public Health and Sanitary Management, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
  • Centre for Translational Research and Systems Medicine, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timișoara, Romania.

ORCID-Profile: Diana-Maria Mateescu, Ovidiu Rosca, Camelia-Oana Muresan

Förderung

  • Victor Babeș University of Medicine and Pharmacy Timișoara
  • Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania

Zitieren

APA

Mateescu, D. M., Toma, A. O., Gavrilescu, D. M., Ilie, A. C., Florescu, E., Rosca, O., Oancea, C., Iurciuc, S., Muresan, C. O., & Enache, A. (2026). Patterns of Antibiotic Use in Hospitalized COVID-19 Patients and Association with Secondary Infections and Outcomes. Antibiotics, 15(3), 240. https://doi.org/10.3390/antibiotics15030240

Vancouver

Mateescu DM, Toma AO, Gavrilescu DM, Ilie AC, Florescu E, Rosca O, et al. Patterns of Antibiotic Use in Hospitalized COVID-19 Patients and Association with Secondary Infections and Outcomes. Antibiotics. 2026;15(3):240. doi:10.3390/antibiotics15030240

BibTeX
@article{Mateescu2026,
  author = {Mateescu, Diana-Maria and Toma, Ana-Olivia and Gavrilescu, Dragos-Mihai and Ilie, Adrian-Cosmin and Florescu, Eduard and Rosca, Ovidiu and Oancea, Cristian and Iurciuc, Stela and Muresan, Camelia-Oana and Enache, Alexandra},
  title = {Patterns of Antibiotic Use in Hospitalized COVID-19 Patients and Association with Secondary Infections and Outcomes},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {240},
  doi = {10.3390/antibiotics15030240}
}
Kostenlos starten →